Using ultrasound to guide heart procedures in patients with kidney disease
Official title: " Contrast-free " IVUS Guided PCI Compared to Standard Angio-guided PCI in Patient With sEvere kidnEy Disease
Run by Assistance Publique - Hôpitaux de Paris · NCT06813534 · Data updated 2026-11-12
This study is testing whether using ultrasound to guide heart procedures can help people with kidney disease avoid serious complications from traditional methods that use contrast dye.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 2 sites (Créteil, Creteil and 1 other locations) |
| Status | Recruiting |
| Started | August 8, 2024 |
| Main results expected | July 7, 2027 |
| Study ends | August 4, 2027 |
| Registry record updated | February 7, 2025 |
| Trial ID | NCT06813534 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with chronic kidney disease and a creatinine clearance of 30 mL/min or less who require a PCI.
✕Probably not a fit
Patients who have undergone iodine contrast injection in the previous 72 hours or those on permanent dialysis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of an intravascular ultrasound (IVUS)-guided approach for performing percutaneous coronary interventions (PCI) in patients suffering from chronic kidney disease (CKD). The focus is on reducing the incidence of contrast-induced nephropathy (CIN), a serious complication that can arise from traditional PCI methods that require iodine contrast. By utilizing a 'zero-contrast' strategy, the study seeks to demonstrate that IVUS can safely guide these procedures without the associated risks of contrast agents. The primary outcome will be the incidence of CIN within 72 hours post-procedure.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of kidney damage in patients with chronic kidney disease undergoing heart procedures.
How similar studies have gone: While many studies have explored pharmacological strategies to prevent CIN, the use of IVUS as a per-procedural strategy in this context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years old * Indication for PCI * Chronic kidney disease with creatinine clearance ≤ 30 mL/min/1.73m² * Feasibility of IVUS determined by 2 trained interventional cardiologist * Affiliated to social security Exclusion Criteria: * Iodine contrast injection in the previous 72 hours * Known allergy to iodine contrast * Permanent dialysis * Chronic total occlusion * Hemodynamic instability * Legal protection * Pregnant of breastfeeding patients * Patients on "AME"
Where it's running
-
Romain GALLET
Créteil, France Recruiting -
Romain GALLET
Créteil, Creteil, France Not yet recruiting
Study contacts
- Study coordinator: Romain GALLET, Pr
- Email: romain.gallet@aphp.fr
- Phone: 01 49 81 21 11
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.